CNBX Pharmaceuticals's total assets for Q were $163.92K, a decrease of -57.69% from the previous quarter. CNBX total liabilities were $2.52M for the fiscal quarter, a 1.62% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.